openPR Logo
Press release

Dexrazoxane Market outlook, analysis, Research Report 2023 - valuates Reports

09-19-2023 01:29 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

An antimitotic agent with immunosuppressive properties. Dexrazoxane, the (+)-enantiomorph of razoxane, provides cardioprotection against anthracycline toxicity. It appears to inhibit formation of a toxic iron-anthracycline complex. [PubChem] The Food and Drug Administration has designated dexrazoxane as an orphan drug for use in the prevention or reduction in the incidence and severity of anthracycline-induced cardiomyopathy

The global Dexrazoxane market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

Get sample report - https://reports.valuates.com/request/sample/QYRE-Auto-8V8460/Global_Dexrazoxane_Market_Insights_Forecast_to_2028

North American market for Dexrazoxane is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Dexrazoxane is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Dexrazoxane include Bedford Laboratories, Topotarget, Pharmacia and Upjohn, Gland Pharma, Mylan, West-Ward Pharms, Clinigen, Boehringer Ingelheim and Clinigen Healthcare, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Dexrazoxane, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dexrazoxane.
The Dexrazoxane market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Dexrazoxane market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dexrazoxane manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Segment by Type
250mg
500mg

Segment by Application
Hospital
Drug Store

Get detailed report - https://reports.valuates.com/market-reports/QYRE-Auto-8V8460/global-dexrazoxane

Similar report-

https://reports.valuates.com/market-reports/QYRE-Auto-35V12776/global-chemotherapy-induced-cardiotoxicity-treatment

https://reports.valuates.com/market-reports/QYRE-Auto-19Y12813/global-dexrazoxane-for-injection

Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137

Email Id:
Please reach us at sales@valuates.com

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dexrazoxane Market outlook, analysis, Research Report 2023 - valuates Reports here

News-ID: 3213365 • Views:

More Releases from Valuates Reports

Aluminium-Scandium Market Share Driven by Growth in Aerospace and Defense Applic …
Aluminium-Scandium- Market Size The global market for Aluminium-Scandium was estimated to be worth US$ 88.1 million in 2024 and is forecast to a readjusted size of US$ 134 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-34R6611/Global_Aluminium_Scandium_Market_Insights_and_Forecast_to_2028 The Aluminium-Scandium market is witnessing strong growth, driven by increasing demand in defense, aerospace, transportation, and consumer goods sectors. The addition of scandium to aluminum alloys enhances strength, corrosion
Yttrium Fluoride Market Share Driven by Growth in Laser and Luminescent Material …
Yttrium Fluoride Market Yttrium fluoride is an inorganic chemica. It is not known naturally in 'pure' form. The fluoride minerals containing essential yttrium include tveitite-(Y) (Y,Na)6Ca6Ca6F42 and gagarinite-(Y) NaCaY(F,Cl)6. Sometimes mineral fluorite contains admixtures of yttrium. The global Yttrium Fluoride market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-4P3813/Global_Yttrium_Fluoride_Market_Insights_Forecast_to_2028 The Yttrium Fluoride
Samarium-149 Market Share Driven by Growth in Nuclear Medicine and Scientific Re …
Samarium-149 Market Size The global market for Samarium-149 was valued at US$ 2.9 million in the year 2024 and is projected to reach a revised size of US$ 4.8 million by 2031, growing at a CAGR of 6.9% during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-21M12149/Global_Samarium_Market_Size_Manufacturers_Supply_Chain_Sales_Channel_and_Clients_2022_2028 The Samarium-149 market is experiencing steady growth, driven by its increasing use in nuclear medicine and scientific research. Its unique radioactive properties make it highly valuable for targeted
Terbium (III) Sulfate Market Share Driven by Growth in Luminous Materials and Ch …
Terbium (III) Sulfate Market The global market for Terbium (III) Sulfate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-24U9164/Global_Terbium_III_Sulfate_Market_Research_Report_2022 The Terbium (III) Sulfate market is witnessing significant growth, fueled by its expanding applications in luminous materials, chemical reagents, and other specialty uses. Its unique luminescent and chemical

All 5 Releases


More Releases for Dexrazoxane

Dexrazoxane for Injection Market Industry Analysis by Size, Share, Growth, Sourc …
" The Dexrazoxane for Injection market is projected to reach a value of approximately $500 million in 2024, driven by its critical role in mitigating cardiotoxicity associated with anthracycline chemotherapy. The anticipated market growth is primarily fueled by increasing cancer prevalence and a rising focus on enhancing patient safety during cancer treatments. Over the forecast period from 2025 to 2034, the market is expected to grow at a CAGR of
Dexrazoxane for Injection market: Players tapping Emerging Markets | Jiangsu Aos …
"The global Dexrazoxane for Injection Market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Dexrazoxane for Injection Market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of
Dexrazoxane Market Sales and Revenue by Companies, Regions, Type and Application …
The Report Hive Research has added a new statistical market report to its repository titled as, Dexrazoxane Market. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data (as applicable). Furthermore, the report also sheds light on recent developments and technological platforms, in addition to distinctive tools, and methodologies that will help to propel Dexrazoxane
Global Dexrazoxane Market 2022 Key Drivers and Restraints, Regional Outlook, End …
MarketsandResearch.biz publishes a Global Dexrazoxane Market research study that looks at the industry, major market trends, and historical and expected market data. A market overview, as well as definitions and applications, are included in the study. The market is segmented by application, type, and geography in terms of volume and value. The investigation's findings are presented in the next section of the chapter. Our analysts provide customers with all of the
Dexrazoxane Market Size, Outlook, Share, Demand, Manufacturers And Forecast To 2 …
LOS ANGELES, United States: The research study presented in this report offers complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the global Dexrazoxane  market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global Dexrazoxane market. The authors of the report have segmented the global Dexrazoxane market as per product, application, and
Dexrazoxane Market is Recovering from Covid-19 Outbreak- More Details About key …
Dexrazoxane hydrochloride is a cardioprotective drug. the dexrazoxane is used to protect the heart from cardiotoxic adverse effects of chemotherapeutic drugs, such as anthracyclines, daunorubicin, doxorubicin, etc. For the prevention of cardiomyopathy for adults and children aged 0 to 16 years, dexrazoxane was approved by the US FDA as an orphan drug for treatment with an anthracycline. Around all children are mandated to receive dexrazoxane at the discretion of the